Disparities in Current Pulmonary Embolism Management and Outcomes
Published: March 20, 2025
- Pulmonary embolism (PE) is a common cause of CV-associated morbidity and mortality, yet its incidence is higher among some racial groups, reproductive-age females and transgender persons taking estrogen hormones.
- Disparities in the diagnosis or management of PE may exist with associations to race, ethnicity, sex, and socioeconomic status, leading to poorer outcomes, including embolic pulmonary hypertension, and mortality.
- This scientific statement summarizes the current evidence for disparities surrounding pulmonary embolism and provides approaches to equitable care for people with PE.
Recommended Reading
- Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension
- Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions
- Health Disparities in Peripheral Artery Disease
- Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease
- Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence
- Home-Based Cardiac Rehabilitation